Gj. Mclaren et al., INVESTIGATION OF THE ACTIONS OF PPADS, A NOVEL P-2X-PURINOCEPTOR ANTAGONIST, IN THE GUINEA-PIG ISOLATED VAS-DEFERENS, British Journal of Pharmacology, 111(3), 1994, pp. 913-917
1 Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) was in
vestigated for its ability to act as an antagonist at P-2x-purinocepto
rs which mediate neurogenic excitatory junction potentials (e.j.ps) an
d contractions in the guinea-pig isolated vas deferens. 2 PPADS (10(-7
) M) caused a small potentiation of the phasic, predominantly purinerg
ic component of contractions evoked by symapthetic nerve stimulation,
but higher concentrations of PPADS (3 x 10-(6) x 10(-5) M) elicited a
substantial and significant concentration-dependent inhibition. In con
trast, over the same concentration-range, PPADS had no effect on the t
onic, predominantly noradrenergic phase. 3 PPADS (3 x 10-(5) M) also i
nhibited contractile responses to exogenous alpha,beta-methyleneATP (1
0(-8)-10(-3) M), a P-2x-purinoceptor agonist, without affecting the re
sponses to exogenous noradrenaline (10(-8)-10(-3) M), carbachol (10(-5
) M) or histamine (10(-4) M).